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Venezuelan equine encephalitis virus replicon particles (VRP) containing the gene expressing hemagglutinin (HA) from the
human Hong Kong Influenza A isolate (A/HK/156/97) were evaluated as vaccines in chicken embryos and young chicks.
Expressed HA was readily detected in bird-tissue staining with anti-H5 HA antibody and in chicken cells infected with the
replicon preparations following immunoprecipitation with monoclonal antibody. Birds challenged with a dose of the lethal
parent virus were protected to different extents depending on the age of the bird. In ovo and 1-day-old inoculated animals
that received no boost with the VRP were partially protected; birds 2 weeks of age were completely protected with a single
dose of VRP. © 2000 Academic Pressg
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iINTRODUCTION
Large-scale vaccination of young birds has proven
an effective method for control of many viral diseases
of poultry (Zander et al., 1997). More recently, vacci-
nation in ovo for Marek’s disease has become wide-
pread in the U.S. broiler chicken industry (Sharma,
999), providing an easy, cost-effective method of
accination against this economically important
isease. The alphavirus expression/replicon system
Schlesinger, 1999) has been shown to be effective as
vaccine delivery tool in mammals. In particular, the
enezuelan equine encephalitis (VEE) system (Pushko
t al., 1997) has been used to protect mice against a
ethal influenza challenge in mice and more recently a
ethal SIV challenge in macaques (Davis et al., 2000).
he effectiveness of vaccination using the alphavirus
ectors, however, has not yet been evaluated in the
vian system. With the recent lethal outbreak of H5N1
vian influenza in Hong Kong in 1997 (Subbarao et al.,
998; Claas et al., 1998; Suarez et al., 1998) affecting
oth birds and humans, it seemed useful to evaluate
he efficacy of the VEE replicon system as a vaccine-
elivery mode for both mammals and birds. It was of
urther interest to determine the effectiveness of the
accine in the late-stage avian embryo, as it was
ecently demonstrated (Gagic et al., 1999) that multiple
ive viruses may be used for successful in ovo vacci-
ation of chickens.
1 To whom correspondence should be addressed.55RESULTS
When VRP containing a copy of the influenza hemag-
lutinin RNA were inoculated onto chicken cells at in-
reasing concentrations, expression of the cleaved influ-
nza HA protein was readily detected by immunoprecipi-
ation of the HA using monoclonal antibodies (Fig. 1).
hree forms of the HA (see Klenk and Garten, 1994)
ould be distinguished in the replicon-infected cells: the
rimeric form, the noncleaved precursor, and the cleaved
onomeric form. In this particular experiment, the con-
entration of HA appeared to be higher in the cells
nfected at 0.5 particle/cell than in cells infected with 50
articles (Lanes 3 and 4). This was not consistently seen
nd was apparently due to variation in our capacity to
uantitatively strip and recover the HA from the immune
omplex. Likewise, though the samples were treated in
tandard fashion with SDS and mercaptoethanol, the
rimeric complex formed again under the electrophoresis
onditions employed. It was clear, however, that the HA
as being expressed at high levels when cells were
nfected with 5 3 103 VRP per cell. The noncleaved HA
was clearly visible at this level of infection, indicating a
level of HA production that apparently exceeded the
cells’ capacity of proteolytic enzymes to process (Fig. 1,
Lane 5, and unpublished observations).
Efficient expression of the H5 HA by the VRPs in
chicken cells was also noted both in white leghorn em-
bryos infected at 19 days incubation (Fig. 2) and in
1-day-old hatchlings (data not shown). Tissues were iso-
lated from control (mock-infected) embryos and from
VEE-HA inoculated chicken embryos 1-day postinocula-
tion (dpi). Positive immunoreactivity using a mouse
monoclonal antibody specific for the H5 protein was0042-6822/00 $35.00
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56 SCHULTZ-CHERRY ET AL.detected in intestines and thymus (Fig. 2), kidney, bursa,
heart, proventriculus, intestines, spleen, and liver. The
staining patterns suggested systemic distribution of the
replicon, with the intestines and thymus appearing to
have the most staining both in embryos and 1-day-old
birds. No immunoreactivity was observed in mock-in-
fected tissues. These results indicate that embryos in-
oculated with the VEE-H5 replicon expressed significant
levels of the HA protein in a variety of embryo tissues.
In order to determine whether VEE replicons would
stimulate an efficient immune response in ovo, 19-day-
old embryos were inoculated and after hatching, birds
were analyzed with and without a subsequent boost with
the VRP, for circulating serum antibodies to the HA pro-
tein. They were then subsequently challenged with lethal
H5N1 virus. In Table 1, the protection levels at the highest
input of VEE-HA replicons was less than 100%. Only one
of seven birds showed a serum hemagglutination inhibi-
tion response to the inoculation and only three of seven
birds were protected against the lethal infection. When
the birds were boosted at 2 weeks of age with an
equivalent dose of replicons, all showed a positive HI
response and all were protected from the lethal infection.
Likewise, as shown in Table 2, 1-day-old hatchlings were
also incompletely protected by VEE-HA replicons alone,
while a boost at 14 days yielded 100% protection. In this
experiment it was also shown that a single dose of
replicons at 14 days of age was capable of providing an
equivalent level of protection against lethal challenge.
To determine the extent of reduction of virus in vacci-
nated birds, in ovo vaccinated birds were assayed for
FIG. 1. VEE replicon expression of HA protein in chicken cells.
Primary chick-embryo cells were infected with varying amounts of
replicon, incubated overnight, and labeled with 35S-methionine. The
roteins were then solubilized and precipitated with monoclonal anti-
ody and protein-A agarose. Precipitates were then electrophoresed in
DS-polyacrylamide gels. Lane 1: control (no replicons); Lane 2: 0.005
RP per cell; Lane 3: 0.5 particles per cell; Lane 4: 50 particles per cell;
ane 5: 5 3 103 particles per cell.virus levels in the oral and cloacal cavities following
immunization and challenge. In Fig. 3 are shown the
results of these assays. A dose of 107 replicons per
mbryo followed by a boost at 14 days of age provided
mmunity against lethal infection with A/HK/156/97
H5N1), and no virus was recoverable at 2 days post-
hallenge. Mock-vaccinated controls, in comparison,
ielded high titers of virus in the oral and cloacal cavities.
DISCUSSION
The alphavirus replicon system for expression of het-
rologous genes has proven to be a potent method for
afe delivery of proteins as immunogens in mammals
Pushko et al., 1997; Davis et al., 2000). This report
emonstrates that the system should be equally useful in
irds. The results clearly demonstrate that a protective
mmune response, capable of decreasing challenge vi-
us replication below measurable levels, is mounted in
-week-old birds inoculated with a single reasonable
ose of VEE-HA replicons. The response in hatchlings
nd in ovo was more variable and less efficient unless a
oost was given. In general, a measurable HI titer
gainst a given subtype means birds will have low levels
r no virus in the oral and cloacal cavities and will be
rotected from a lethal challenge by the same subtype.
n some cases birds are protected from lethal infection
ven though they do not exhibit a measurable serum HI
esponse. This is not uncommon and has been reported
FIG. 2. Expression of H5 HA in chicken embryo tissues. Tissues
were removed from chicken embryos infected with the VEE-HA repli-
cons or noninfected controls at 1 day postinfection and stained for the
presence of the H5 hemagglutinin. (A) Intestinal tissue from infected
embryos, bar 5 150 mm. (B) Thymus from infected embryos, bar 5 100
mm. (C) Intestinal tissue from control embryos, bar 5 250 mm. Arrows
(brown staining) indicate positive reactions.
57CHICKEN INFLUENZA VIRUS HEMAGGLUTININin other vaccination studies (Crawford et al., 1998, 1999;
Stone et al., 1997), as well as in this study. It may reflect
a number of possibilities including effects of mucosal
immunity or temporally variable low serum HI titers in
younger birds.
Many alphaviruses are found naturally in birds (see
Perdue, 2000), including Sindbis virus (Frolov et al.,
1996), and it is possible that a different alphavirus can-
didate might be found that would induce a stronger
response in the younger birds. The lower levels of anti-
body seen in ovo and in 1-day-old hatchlings may have to
do with the status of the still-developing immune system
in young birds. A single injection of killed virus in oil
emulsion in ovo or subcutaneously in 1-day-old hatch-
lings is capable of eliciting 100% protection in challenges
as long as 8–10 weeks following vaccination (Stone et
al., 1997; Crawford et al., 1998; unpublished observa-
tions). So, at least some elements of the immune system
are in place to mount an effective response. Other prob-
lems with in ovo effectiveness may include the presence
of proteases in the allantoic fluid that could affect the
efficiency of the infection with the VEE replicons. Since in
ovo vaccination of chickens has become a routine prac-
tice by the poultry industry, it will be well worth pursuing
studies that will optimize the immune response in birds
by altering the VEE system or perhaps developing an-
other alphavirus replicon system.
T
In Ovo Vaccination and Boost with VEE Replic
Inoculum
Number of
eggs
inoculated
Number of birds
with HI
response
PBS 1 PBS boost 4 0
4 0
106 H5HA replicons
1 106 H5HA boost 7 1
6 5
107 H5HA replicons
1 107 H5HA boost 7 1
6 6
a Embryos were 19 days old, hatched two days later, and were boo
T
Vaccination of 1- and 14-day-old Chicks with a Single D
Inoculum
Number of
birds
vaccinated
Number of
birds with HI
titers at day o
challenge
PBS control 8 0
107 H5HA (1 day old) 8 1
107 H5HA (14 days old) 8 8
107 H5HA (1 1 14 days old)a 8 8
a Vaccinated at 1 day of age (posthatching) and boosted at 14 daysThe VEE replicon system is certainly effective as a
vaccine in the 2-week-old bird. The protection against
challenge seen with a single injection is comparable to
that seen previously with single injections of either killed
virus or HA subunit vaccines against H5 subtypes (Craw-
ford et al., 1998, 1999), though HI titers were lower. It is
also possible that including other influenza genes in the
vaccination scheme might further enhance the immune
response. Initial results with combined vaccination with
the VEE replicons expressing the N1 neuraminidase and
the H5 HA did not show enhanced protection (data not
shown). Including internal genes expressed by the rep-
licons in the combination, however, might enhance the
cellular immune response and provide broader protec-
tion; these studies are underway.
Preliminary results have also shown the VEE-HA rep-
licons to be effective immunogens in mice (Dybing, un-
published data). It has been previously shown that an H3
subtype HA expressed by an attenuated VEE vector
system fully protected mice against a lethal influenza
challenge as well (Davis et al., 1995). In a zoonotic
outbreak such as the one that occurred in Hong Kong in
1997, it would be useful to devise a vaccine that would
have common antigens that would be effective for both
humans and nonhumans. The VEE replicon system might
provide just such an effective candidate.
pressing Influenza H5 Hemagglutinin Proteina
Range of HI
titers–day of
challenge
Number of birds
surviving
challenge
Range of HI
titers–10-d
postchallenge
0 0 NA
0 0 NA
0–4 1 .256
0–128 5 .256
0–4 3 .256
32–128 6 .256
2 wks posthatching.
VEE Replicons Expressing Influenza H5 Hemagglutinin
Range of HI titer–
day of challenge
Number of birds
surviving challenge
Range of HI
titer–10-d
postchallenge
0 0 NA
0–2 3 128–256
16–64 8 32–256
4–256 8 16–256
tching.ABLE 1
ons Ex
sted atABLE 2
ose of
f
postha
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Vector development. The complete coding sequence
of the hemagglutinin (HA) gene from A/Hong Kong/
156/97 (H5N1) strain (originally isolated from a 3-year-old
child in Hong Kong in April 1997) was RT-PCR amplified,
cloned into the pAMP vector (Gibco, Gaithersburg, MD),
and sequenced as previously described (Suarez et al.,
1998). The plasmid containing the complete HA coding
sequence was used as template in a PCR reaction with
two primers comprising (for forward, VEE genome-
sense, 59 to 39) a random 8-mer, a ClaI site, the distal 16
nucleotides of the 26S mRNA untranslated region, and
the first nine codons of the HA gene, and (for reverse,
complementary, 59 to 39) a random 8-mer, a ClaI site, a
stop codon, and the 39-terminal 14 nucleotides of the HA
gene. A DNA fragment of the expected size was ampli-
FIG. 3. Virus titers in chickens vaccinated in ovo with VEE-HA and ch
X axis represents challenge virus titers from the oral cavity and cloaca
plus boost with PBS. (C) Embryos vaccinated with 106 VRP. (D) Embryos
06 VRP. (E) Embryos vaccinated with 107 VRP. (F) Embryos vaccinatedfied using 25 cycles of 93°C for 1 min, 55°C for 2 min,
and 72C for 1 min with Vent DNA polymerase (New
England Biolabs) in a DNA Thermal Cycler (Perkin–Elmer
Cetus). The purified DNA fragment was digested with
ClaI and inserted at the unique ClaI site of a replicon
vector plasmid, pVR2, analogous to that described by
Pushko et al. (1997). The sequence of the insert was
confirmed, and virus replicon particles (VRP) were pro-
duced by coelectroporation of baby hamster kidney
(BHK) cells with three in vitro RNA transcripts, pVR2-HA
replicon, VEE capsid helper, and VEE mutant glycopro-
tein helper, exactly as described (Pushko et al., 1997).
Serial dilutions of HA-VRP preparations were used to
infect BHK cell monolayers in eight-well chamber slides.
VRP-infected single cells were scored by indirect immu-
nofluorescence using anti-influenza virus A/Hong Kong/
d with a lethal dose of A/Hong Kong/156/97 (H5N1). Each point on the
of the same chicken. (A) Control (mock vaccinated) birds. (B) Control
ated with 106 particles plus a boost at 14 days of age with an additional
07 particles plus a boost at 14 days of age with an additional 106 VRP.allenge
l cavity
vaccin
with 1
s
s
i
e
a
c
r
c
(
p
A
b
a
s
t
d
f
h
m
A
f
u
C
D
D
D
F
G
K
P
P
P
S
S
S
S
S
Z
59CHICKEN INFLUENZA VIRUS HEMAGGLUTININ156/97 chicken serum, biotinylated anti-chicken IgG
(Vector Laboratories, Inc., Burlingame, CA), and avidin
FITC.
Immunoprecipitation. Primary chicken-embryo cells
were inoculated with varying concentrations of replicons
and then incubated for 24 h. The cells were disrupted
and processed as previously described in buffer contain-
ing Triton X-100 and sodium deoxycholate (Perdue, 1992),
and proteins were precipitated using monoclonal anti-
body specific for the HA of A/Hong Kong/156/97. Gels
were run and processed for autoradiography as de-
scribed (Perdue, 1992).
Vaccination and challenge. Embryos were inoculated
as described by Stone et al. (1997) at 18 or 19 days of
development. Briefly, a 112 in. 28-gauge needle was in-
erted full length into a hole drilled in the top of the air
ac end of the egg and 0.1 ml of buffer or buffer-contain-
ng replicons was injected. The hole was sealed and the
mbryo hatched. In these experiments hatch rate was
lways greater than 95%. One-day-old and 2-week-old
hickens were vaccinated subcutaneously with 0.2 ml of
eplicons in the nape of the neck. Vaccinated birds were
hallenged at 4 weeks of age by intranasal/intratracheal
IN/IT) inoculation with 10,000 egg lethal doses (ELD50)
er animal with an embryo-propagated stock of the
/HK/156/97 H5N1 strain. Serum hemagglutination inhi-
ition (HI) titers and titration of virus recovered from oral
nd cloacal cavities were determined as previously de-
cribed (Crawford et al., 1998, 1999).
Immunohistochemistry. Briefly, tissues were removed
from chicken embryos 1 day postinoculation with PBS or
VEE-H5 replicon and snap frozen in liquid nitrogen in
OCT freezing compound (Fisher Scientific, Norcross,
GA). Frozen tissues were cut into 6-mm sections and
hawed on Vectabond-coated microscope slides. The
ried tissues were fixed with cold 1:1 methanol/acetone
or 3 min at room temperature, blocked with 1% normal
orse serum in PBS, and stained with a 1:500 dilution of
ouse monoclonal anti-H5 antibody using the Vector
BC alkaline phosphatase staining kit following manu-
acturer’s directions (Vector Laboratories). Fast Red was
sed as the alkaline phosphate substrate.
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